Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL-Reference-Cited by-同舟云学术

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

Published:2018-02-15 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Schrader A.,Crispatzu G.,Oberbeck S.,Mayer P.,Pützer S.,von Jan J.,Vasyutina E.,Warner K.,Weit N.,Pflug N.,Braun T.,Andersson E. I.^ORCID,Yadav B.,Riabinska A.,Maurer B.,Ventura Ferreira M. S.,Beier F.,Altmüller J.,Lanasa M.,Herling C. D.,Haferlach T.,Stilgenbauer S.,Hopfinger G.,Peifer M.^ORCID,Brümmendorf T. H.,Nürnberg P.,Elenitoba-Johnson K. S. J.,Zha S.,Hallek M.,Moriggl R.^ORCID,Reinhardt H. C.,Stern M.-H.^ORCID,Mustjoki S.,Newrzela S.,Frommolt P.,Herling M.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-02688-6.pdf

Reference77 articles.

1. Herling, M. et al. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 104, 328–335 (2004).

2. Matutes, E. et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 78, 3269–3274 (1991).

3. Dearden, C. How I treat prolymphocytic leukemia. Blood 120, 538–551 (2012).

4. Hopfinger, G. et al. Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia. Cancer 119, 2258–2267 (2013).

5. Herling, M. et al. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. Blood 111, 328–337 (2008).

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family–negative T-prolymphocytic leukemia;American Journal of Clinical Pathology;2024-06-30

2. Does a subset of mature T‐cell leukemias with features akin to T‐cell prolymphocytic leukemia but lacking rearrangement of the TCL1 represent peripheral T‐cell lymphoma, NOS in a leukemic phase?;eJHaem;2024-06-17

3. Discovery of molecularly-informed therapeutic strategies for mature T-cell neoplasms;2024-06-13

4. The critical role of phytohemagglutinin‐stimulated cell cultures in the diagnosis of T‐cell prolymphocytic leukemia: A case‐based approach;International Journal of Laboratory Hematology;2024-06-04

5. What is new in the 5th edition of the World Health Organization classification of mature B and T/NK cell tumors and stromal neoplasms?;Journal of Hematopathology;2024-04-29